Data for: Enhanced antitumor effects of CD123/CD33 dual-antibody modified liposome targeting to acute myeloid leukemia cells with reduced the antigen-negative escape

Published: 18 July 2019| Version 1 | DOI: 10.17632/6phjx8s467.1
Contributor:
ShengJun Mao

Description

A dual-targeting drug delivery system was developoed to enhance the therapeutic efficacy of chemotherapeutics and reduce the antigen-negative escape for Acute myeloid leukemia.

Files

Categories

Drug Delivery, Pharmaceutics, Acute Leukemia

Licence